Takeda Pharmaceutical Company Limited
ADIPOSE TISSUE-DERIVED STROMAL STEM CELLS FOR USE IN TREATING REFRACTORY COMPLEX PERIANAL FISTULAS IN CROHN'S DISEASE
Last updated:
Abstract:
Provided herein are expanded allogeneic adipose tissue-derived stromal stem cells for use in treating complex perianal fistulas in Crohn's Disease.
Status:
Application
Type:
Utility
Filling date:
14 Feb 2022
Issue date:
11 Aug 2022